Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study

References

• Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, . Takayasu arteritis. Ann Intern Med 1994;120:919–29.
   PubMed Web of Science ®Google Scholar
• Mason JC. Takayasu arteritis. Nat Rev Rheumatol 2010;6:406–15.
   PubMed Web of Science ®Google Scholar
• Borg FA, Dasgupta B. Treatment and outcomes of large vessel arteritis. Best Pract Clin Res Rheumatol 2009;23:325–37.
   PubMed Web of Science ®Google Scholar
• Maksimowicz-McKinnon K, Hoffman GS. Takayasu arteritis: what is the long term prognosis? Rheum Dis Clin N Am 2007; 33:777–86.
   PubMed Web of Science ®Google Scholar
• Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994;37:578–82.
   PubMed Web of Science ®Google Scholar
• Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu’s arteritis. J Rheumatol 2003;30:1793–8.
   PubMed Web of Science ®Google Scholar
• Shinjo SK, Pereira RM, Tizziani VA, Radu AS, Levy-Neto M. Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol 2007;26:1871–5.
   PubMed Web of Science ®Google Scholar
• Goel R, Danda D, Mathew J, Edwin N. Mycophenolate mofetil in Takayasu’s arteritis. Clin Rheumatol 2010;29:329–32.
   PubMed Web of Science ®Google Scholar
• Shelhamer JH, Volkman DJ, Parrillo JE, Lawley TJ, Johnston MR, Fauci AS. Takayasu’s arteritis and its therapy. Ann Intern Med 1985;103:121–6.
   PubMed Web of Science ®Google Scholar
• Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 2007;56:1000–9.
   PubMed Web of Science ®Google Scholar
• Park MC, Lee SW, Park YB, Chung NS, Lee SK. Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 2005;34:284–92.
   PubMed Web of Science ®Google Scholar
• Arnaud L, Haroche J, Limal N, Toledano D, Gambotti L, Costedoat Chalumeau N, . Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Medicine (Baltimore) 2010;89:1–17.
   PubMed Web of Science ®Google Scholar
• Vanoli M, Daiana E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, . Takayasu’s arteritis: a study of 104 Italian patients. Arthritis Rheum 2005;53:100–7.
   PubMed Web of Science ®Google Scholar
• Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, . Takayasu’s arteritis in Turkey – clinical and angiographic features of 248 patients. Clin Exp Rheumatol 2009;27:S59–64.
   PubMed Web of Science ®Google Scholar
• Karageorgaki ZT, Bertsias GK, Mavragani CP, Kritikos HD, Spyropoulou-Vlachou M, Drosos AA, . Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol 2009;27:S33–9.
   Web of Science ®Google Scholar
• Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004;50:2296–304.
   PubMed Web of Science ®Google Scholar
• Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS. Anti-tumor necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008;67:1567–9.
   PubMed Web of Science ®Google Scholar
• Behrens F, Koehm M, Burkhardt H. Update 2011: leflunomide in rheumatoid arthritis – strengths and weakness. Curr Opin Rheumatol 2011;23:282–7.
   PubMed Web of Science ®Google Scholar
• Haberhauer G, Kittl EM, Dunky A, Feyertag J, Bauer K. Beneficial effects of leflunomide in glucocorticoid- and methotrexate-resistant Takayasu’s arteritis. Clin Exp Rheumatol 2001;19:477–8.
   PubMed Web of Science ®Google Scholar
• Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, . The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129–34.
   PubMed Web of Science ®Google Scholar
• Kraemer B, Abele H, Hahn M, Rajab T, Kraemer E, Wallweiner D, . A successful pregnancy in a patient with Takayasu’s arteritis. Hypertens Pregnancy 2008;27:247–52.
   PubMed Web of Science ®Google Scholar
• Freitas DS, Camargo CZ, Mariz HA, Arraes AE, de Souza AW. Takayasu arteritis: assessment of response to therapy based on clinical activity criteria and imaging techniques. Rheumatol Int. 2010 Dec 9. [Epub ahead of print], DOI 10.1007/s00296-010-1694-9.
   Google Scholar
• Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large vessel-vasculitis: an update. Rheumatology (Oxford) 2008;47:403–8.
   PubMed Web of Science ®Google Scholar